Patient Care
Making metabolic health a priority
December 1, 2025
UT San Antonio has a bold vision for the future of metabolic health that is reflected in our mission. We strive every day to make lives better for the people of Texas and beyond by bringing the power of science to the bedside, to the community and to the next generation of scientists and physicians.
Redefining obesity
December 1, 2025
New obesity treatments must factor in the complexity of the condition and the connection to chronic disease.
Better together
December 1, 2025
Dr. Ralph DeFronzo proposes treating diabetes with combination drug therapy rather than single medications. His research highlights pioglitazone, a powerful but underused insulin sensitizer, which, when paired with GLP-1 agonists and SGLT2 inhibitors, can control diabetes in up to 95% of patients.
Bold research aims to halt liver disease before it turns deadly
December 1, 2025
Researchers, including Dr. Luke Norton and Dr. Madesh Muniswamy, are leading efforts to understand and prevent metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH).
Advances in preventing and treating diabetic neuropathy
December 1, 2025
Dr. Lee Rogers and Dr. Monica Verduzco-Gutierrez lead research and care to prevent diabetic neuropathy and limb amputations with new remote monitoring technologies.
Centers bring together science and care to take on diabetes and metabolic disorders
November 30, 2025
The Center for Molecular Metabolism and the newly opened Center for Excellence in Diabetes, serve as important hubs that foster communication and collaboration among investigators and help turn research findings into real-world impact.